Utility of Serum HE4 in Diagnosis and Prognosis of Endometrial Cancer

被引：0
|
作者：
O'Toole, S. A. [1 ]
Rizmee, S. [2 ]
Norris, L. [1 ]
Cullen, M. [1 ]
Zainulabdin, A. [1 ]
Long, J. C. [1 ]
Martin, F. [1 ]
Cooney, A. [1 ]
Ripollone, S. [1 ]
Ibrahim, N. [1 ]
Abu Saadeh, F. [1 ]
Kamran, W. [2 ]
Murphy, C. [3 ]
D'Arcy, T. [2 ]
Gleeson, N. C. [2 ]
O'Leary, J. J. [1 ]
机构：
[1] Univ Dublin Trinity Coll, Dublin 2, Ireland
[2] St James Hosp, Dublin 8, Ireland
[3] Coombe Womens & Infants Univ Hosp, Dublin, Ireland
来源：
JOURNAL OF PATHOLOGY | 2015年 / 237卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：S15 / S15
页数：1
相关论文
共 50 条
  • [21] Further insight into prognostic factors in endometrial cancer: the new serum biomarker HE4
    Capriglione, Stella
    Plotti, Francesco
    Miranda, Andrea
    Lopez, Salvatore
    Scaletta, Giuseppe
    Moncelli, Michele
    Luvero, Daniela
    Nardone, Carlo De Cicco
    Terranova, Corrado
    Montera, Roberto
    Angioli, Roberto
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (01) : 9 - 18
  • [22] HE4 as a biomarker for ovarian and endometrial cancer management
    Li, Jinping
    Dowdy, Sean
    Tipton, Tracy
    Podratz, Karl
    Lu, Wei-Guo
    Xie, Xing
    Jiang, Shi-Wen
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2009, 9 (06) : 555 - 566
  • [23] Prognostic value of serum HE4 level in the management of endometrial cancer: A pilot study
    Rajadevan, Niveditha
    McNally, Orla
    Neesham, Deborah
    Richards, Anthony
    Naaman, Yael
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2021, 61 (02): : 284 - 289
  • [24] Utility of HE4 to identify patients with endometrioid endometrial cancer who may require lymphadenectomy
    Dobrzycka, Bozena
    Mackowiak-Matejczyk, Beata
    Terlikowska, Katarzyna Maria
    Kinalski, Maciej
    Terlikowski, Slawomir Jerzy
    ADVANCES IN MEDICAL SCIENCES, 2016, 61 (01): : 23 - 27
  • [25] Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses
    Gentry-Maharaj, Aleksandra
    Burnell, Matthew
    Dilley, James
    Ryan, Andy
    Karpinskyj, Chloe
    Gunu, Richard
    Mallett, Susan
    Deeks, Jon
    Campbell, Stuart
    Jacobs, Ian
    Sundar, Sudha
    Menon, Usha
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (01)
  • [26] Utility of a novel serum tumor biomarker HE4 in patients with uterine cancer.
    Moore, R. G.
    Brown, A. K.
    Miller, C. M.
    Badgwell, D.
    Lu, Z.
    Verch, T.
    Allard, J. W.
    Granai, C. o.
    Bast, R.
    Lu, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 264S - 264S
  • [27] The value of serum HE4 in pancreatic adenocarcinoma diagnosis
    Ge, Xin
    Zhang, Xiaolei
    Li, Ming
    Deng, Fang
    Shan, Wulin
    Chen, Shaohua
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (05): : 5618 - 5623
  • [28] Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance
    Donal J Brennan
    Andreas Hackethal
    Kristy P Mann
    Irene Mutz-Dehbalaie
    Heidi Fiegl
    Christian Marth
    Andreas Obermair
    BMC Cancer, 15
  • [29] Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance
    Brennan, Donal J.
    Hackethal, Andreas
    Mann, Kristy P.
    Mutz-Dehbalaie, Irene
    Fiegl, Heidi
    Marth, Christian
    Obermair, Andreas
    BMC CANCER, 2015, 15
  • [30] Utility of HE4 and CA-125 as predictive and prognostic factors in preoperative assessment of endometrial cancer
    Gao, M.
    Zhang, N.
    Gao, Y.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 164 - 164
12345